Page 12 - Memora anual Fundación CIEN 2017

▄▀ 1.3 Letter from the Managing Director Mª Ángeles Pérez
It is my pleasure to address you at the end of this spe- Together with the results of the "Vallecas Project",
cial year for us, in which the Queen Sofia Foundation
Alzheimer Center has completed 10 years, to review
the milestones that marked 2017 and strengthened
our role as leaders in research in neurodegenerative
diseases.
Thanks to the constant support of the Queen Sofia
Foundation and the work of those who make up the
CIEN Foundation, we have continued our work of
María Ángeles Pérez Muñoz
CIEN Foundation Managing Director
applied research in a field of great importance for
the health and well-being of our society. Guided by
our commitment to a translational research model
and the internationalization of our projects, we have
contributed new advances in the areas of basic, cli-
nical and epidemiological neurology to the scienti-
fic community.
Our scientific activity has turned into the publication
of 31 original articles in specialized journals, 22 of
them classified in the first and second quartiles. An
upward trend that demonstrates the quality of the
research carried out at the CIEN Foundation. Like-
wise, 50% of the works published in 2017 are the result
of collaboration with prestigious international institu-
tions.
The "Vallecas Project" continues to be one of our
main projects. The success of this study to advance
the early diagnosis of Alzheimer's disease has made
it possible that, at the end of the year, in the fifth fo-
llow-up visit, 658 volunteers have participated while
we have begun the sixth visit. We want to thank and
recognize their work in favor of research to all volun-
teers, since our work would not be possible without
their collaboration.
other current research activities were presented at
the Global Summit Alzheimer's Research Lisbon 2017
organized by the Queen Sofia Foundation and the
CIEN Foundation jointly with the Champalimaud
Foundation and CIBERNED. A special edition of the
already well established International Congress of
Research and Innovation in Neurodegenerative Di-
seases (CIIIEN), chaired and inaugurated by Queen
Sofia and the President of the Portuguese Republic,
Marcelo Rebelo de Sousa, convened for the fifth
consecutive year with scientists of recognized pres-
tige, including Richard Axel and John O'Keefe,
Nobel Laureates in Medicine in 2004 and 2014, res-
pectively to discuss Parkinson's, Alzheimer's and